Naropin Injection, Solution
Product Images NDC 63323-285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Naropin (NDC 63323-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Nar03 0002 01)

FDA Label Image

Premierprorx Logo (Nar03 0002 02)

FDA Label Image

Vial (Nar03 0002 03)

Vial (Nar03 0002 03)
This text provides information on a medical product labeled as "Lift" with the NDC code 63323-285-53. It contains Ropivacaine HCI and sodium chloride in each milliliter, with pH adjusted to 4.0-6.0 using sodium hydroxide and/or hydrochloric acid. The solution contains no preservatives and should not be used if discolored or contains a precipitate. The product is for Infiltration, Nerve Block, and Epidural Administration only and should not be administered intravenously. It is advised to consult the package insert for dosage instructions and to discard any unused portion for single-dose use only.*
FDA Label Image

Bottle (Nar03 0002 04)

Bottle (Nar03 0002 04)
This is a product label for a medication called "LIFT HENEN e." The medication contains Ropivacaine HCI and sodium chloride. It is intended for infiltration, nerve block, and epidural administration but should not be administered intravenously. Each mL contains 2 mg of Ropivacaine HCI and 8.6 mg of sodium chloride. The container closure is not made with natural rubber latex. The medication comes in a 200mL container, and single doses should be discarded after use. Consult the package insert for dosage information and complete prescribing details.*
FDA Label Image

Vial (Nar03 0002 05)

Vial (Nar03 0002 05)
This is a description of Naropin (ropivacaine hydrochloride) injection, USP. It is indicated for infiltration, nerve block, and epidural administration only, not for intravenous administration. Each mL contains 5 mg of Ropivacaine HCI and 8 mg of Sodium chloride. The pH is adjusted to 4.0 to 6.0 with sodium hydroxide and/or hydrochloric acid. It is available in a 30 mL single-dose vial by PREMIERProRx®. The product should be stored at 20°C to 25°C (68°F to 77°F). Naropin is a trademark of Fresenius Kabi USA, LLC. Produced by Fresenius Kabi in Lake Zurich, IL. Lot/Exp: 402868D.*
FDA Label Image

Carton (Nar03 0002 06)

Carton (Nar03 0002 06)
This text provides information about a medication in a 30mL single-dose vial, containing Ropivacaine HCl 5mg, NaCl 8mg, and sodium hydroxide and/or hydrochloric acid to adjust pH. The solution has no preservatives and is designed for Infiltration, Nerve Block, and Epidural Administration only - not for Intravenous use. It also mentions storage conditions, potential discoloration or precipitation issues, and recommends consulting the package insert for dosage and full prescribing information. The product is associated with the trademark "SKYBLUE" and the company details can be found at www.freseniuskabi.com/us.*
FDA Label Image

Vial (Nar03 0002 07)

Vial (Nar03 0002 07)
This is a description of a pharmaceutical product called Naropin®. It is an injection containing Ropivacaine HCI and Sodium chloride for Infiltration, Nerve Block, and Epidural Administration. The product is not intended for Intravenous Administration. Each mL contains 2 mg of Ropivacaine HCI and 8.6 mg of Sodium chloride. It is stored at a temperature range of 20°C to 25°C (68°F to 77°F). The manufacturer is Fresenius Kabi and Naropin® is their trademark.*
FDA Label Image

Vial (Nar03 0002 08)

Vial (Nar03 0002 08)
This is a description of a pharmaceutical product containing Ropivacaine HCI. It is a solution indicated for infiltration, nerve block, and epidural administration. The product is packaged in 20 mL single-dose vials and does not contain natural rubber latex in the container closure. The pH of the solution is adjusted to 4.0 to 6.0 using sodium hydroxide and/or hydrochloric acid. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). It is advised to consult the package insert for dosage and full prescribing information before use. Autoclaving instructions are provided in the package insert. The brand name of the product is Naropin, and it is a trademark of Fresenius Kabi USA, LLC.*
FDA Label Image

Vial (Nar03 0002 09)

Vial (Nar03 0002 09)
This text appears to be a description of a medication called Naropin (ropivacaine hydrochloride) Injection, USP. It is formulated for infiltration, nerve block, and epidural administration only, not for intravenous administration. Each mL contains 5 mg of Ropivacaine HCI and 8 mg of Sodium chloride, with the pH adjusted to 4.0 to 6.0. It is recommended to store this medication at 20°C to 25°C (68°F to 77°F). Naropin is a trademark of Fresenius Kabi USA, LLC. The manufacturer is Fresenius Kabi located in Lake Zurich, IL.*
FDA Label Image

Vial (Nar03 0002 10)

Vial (Nar03 0002 10)
This text is a label of a pharmaceutical product called NAROPIN. It contains Ropivacaine HCI with each mL containing 5 mg. The solution is for Infiltration, Nerve Block, and Epidural Administration Only, not for Intravenous Administration. It instructs to store between 20°C to 25°C and mentions that the container closure is not made with natural rubber latex. The product is produced by Fresenius Kabi USA, LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.